SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GENZYME - THE KING OF THE BIOTECHS
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
410 21 0 GENZ
Emcee:  ajcmr Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
285 Free On-Line Newsletter- Insider Analysis of Genzyme Inforrmation provided to Caveat Emptor-7/14/1998
284 Further Information - Genzyme Development Partners, LP Re: Form 10K - Genzyme Caveat Emptor-7/14/1998
283 Further Information-Insider Shift and General Partnership It is important thatCaveat Emptor-7/13/1998
282 Recent Insider Shift Information. Recent 13D filing of Paine Webber R+D PartneCaveat Emptor-7/13/1998
281 Market conditions for biotech IPOs are currently awful. V1 Vector1-7/9/1998
280 What happened to the Genzyme Molecular Oncology Division IPO? Company pulled itCaveat Emptor-7/9/1998
279 I DONT BUY ANYTHING KING HENRY (HENRI FOR THE EUROPEANS OUT THERE) HAS TO SAY..aliveinsf-6/30/1998
278 TITLE: Genzyme General Clarifies Position in Gaucher's Disease Market DATERobert Floyd-6/23/1998
277biz.yahoo.com GENZ news MINNEAPOLIS, June 23 /PRNewswire/ -- TECHNE Corporatibluejeans-6/23/1998
276 MORE HYPE>>>>LESS PERFORMANCE======DOG King Henry continues to tryaliveinsf-6/11/1998
275 The audio and slide presentation from Genzyme Corp.'s Annual Meeting is beiCampbell-5/27/1998
274 Don't overlook the potential of RenaGel. This product could very well add Robert Holmes-5/27/1998
273 I have held Genz for a couple of month 18 month ago and studied it in detail. ISpekulatius-5/26/1998
272 Thanks for the post. Surgical products can be a very good business, but you haLighthouse-5/22/1998
271 Agreed! More effort in the surgical products area is probably not the best lonHarold Engstrom-5/22/1998
270 Hello! I enjoyed reading your take on the organizational "issues" faLighthouse-5/21/1998
269 Interesting article in the Boston Globe today covering Genzyme's marketing Dave Chanoux-5/8/1998
268 Genzyme is an interesting company. I don't think anyone except the select Harold Engstrom-3/18/1998
267 There were times when Genz looked cheap to us and times not. Our cost basis isH. Bradley Toland, Jr.-3/18/1998
266 GENZ UNDERPERFORMS RELATIVE TO AMGN BGEN What long term chart are you looking aliveinsf-3/17/1998
265 38 was too much to pay for the stock then. One can overpay for anything. Look aH. Bradley Toland, Jr.-3/16/1998
264 I am talking about GENZ...a stock that was at 32 in Aug 95, 38 in Jan 96 and unaliveinsf-3/16/1998
263 Bradley, I bought this stock in summer '96 and it has moved up from 22 to nHarold Engstrom-3/16/1998
262 the stock has moved from 15 to 32 over the past coupe of years and the productH. Bradley Toland, Jr.-3/16/1998
261 This company is a classic underachiever of all the biotechs...King Henri spendsaliveinsf-3/13/1998
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News